DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG

被引:0
|
作者
Kanou, M. [1 ]
Nishiwaki, Y. [2 ]
Nakano, A. [2 ]
Yamanaka, Y. [2 ]
机构
[1] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Tokyo, Japan
[2] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Tokyo, Japan
关键词
D O I
10.1016/S1567-5688(10)70360-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P293
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [1] DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR (CAI) AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG
    Kanou, M.
    Nisiwaki, Y.
    Nakano, A.
    Sugimoto, Y.
    Yamanaka, Y.
    Kondo, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [2] Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor
    Imaeda, Yasuhiro
    Tokuhara, Hidekazu
    Fukase, Yoshiyuki
    Kanagawa, Ray
    Kajimoto, Yumiko
    Kusumoto, Keiji
    Kondo, Mitsuyo
    Snell, Gyorgy
    Behnke, Craig A.
    Kuroita, Takanobu
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 933 - 938
  • [3] Discovery and development of anacetrapib, a potent and orally active CETP inhibitor
    Ali, Amjad
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [4] Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase
    Li, Xinnan
    Ze, Xiaotong
    Zhou, Shengnan
    Hu, Zhaoxin
    He, Chen
    Jia, Yilin
    Liu, Lihua
    Wang, Tao
    Li, Junda
    Xu, Shengtao
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Yao, Hequan
    Xu, Jinyi
    Yao, Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5118 - 5153
  • [5] Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor
    Iijima, Daisuke
    Sugama, Hiroshi
    Takahashi, Yoichi
    Hirai, Miki
    Togashi, Yuko
    Xie, Jianshu
    Shen, Jingkang
    Ke, Ying
    Akatsuka, Hidenori
    Kawaguchi, Takayuki
    Takedomi, Kei
    Kashima, Akiko
    Nishio, Masashi
    Inui, Yosuke
    Yoneda, Hikaru
    Xia, Guangxin
    Iijima, Toru
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 10882 - 10897
  • [6] Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6
    Shimamura, Ken
    Nagumo, Akira
    Miyamoto, Yasuhisa
    Kitazawa, Hidefumi
    Kanesaka, Maki
    Yoshimoto, Ryo
    Aragane, Katsumi
    Morita, Naomi
    Ohe, Tomoyuki
    Takahashi, Toshiyuki
    Nagase, Tsuyoshi
    Sato, Nagaaki
    Tokita, Shigeru
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 630 (1-3) : 34 - 41
  • [7] Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
    Dorsey, Bruce D.
    Iqbal, Mohamed
    Chatterjee, Sankar
    Menta, Ernesto
    Bernardini, Raffaella
    Bernareggi, Alberto
    Cassara, Paolo G.
    D'Arasmo, Germano
    Ferretti, Edmondo
    De Munari, Sergio
    Oliva, Ambrogio
    Pezzoni, Gabriella
    Allievi, Cecilia
    Strepponi, Ivan
    Ruggeri, Bruce
    Ator, Mark A.
    Williams, Michael
    MallamoT, John P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 1068 - 1072
  • [8] Discovery of DS79182026: A potent orally active hepcidin production inhibitor
    Fukuda, Takeshi
    Goto, Riki
    Kiho, Toshihiro
    Ueda, Kenjiro
    Muramatsu, Sumie
    Hashimoto, Masami
    Aid, Anri
    Watanabe, Kengo
    Tanaka, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (16) : 3716 - 3722
  • [9] Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor
    Miyazaki, Masaki
    Uoto, Kouichi
    Sugimoto, Yuuichi
    Naito, Hiroyuki
    Yoshida, Keisuke
    Okayama, Tooru
    Kawato, Haruko
    Miyazaki, Masaya
    Kitagawa, Mayumi
    Seki, Takahiko
    Fukutake, Setsuko
    Aonuma, Masashi
    Soga, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2360 - 2367
  • [10] Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor
    He, Pengxing
    Niu, Shenghui
    Wang, Shuai
    Shi, Xiaojing
    Feng, Siqi
    Du, Linna
    Zhang, Xuyang
    Ma, Zhilu
    Yu, Bin
    Liu, Hongmin
    ACTA PHARMACEUTICA SINICA B, 2019, 9 (06) : 1193 - 1203